Tumor-associated macrophages (TAMs) have multifaceted roles in tumor development, particularly linked with tumor angiogenesis and invasion, but the molecular mechanism underlying this association remains unclear. In this study, we report that lack of osteopontin (OPN) suppresses melanoma growth in opn À / À mice and macrophages are the crucial component responsible for OPN-regulated melanoma growth. In tumor microenvironment, OPN activates macrophages and influences angiogenesis by enhancing cyclooxygenase-2 (COX-2)-dependent prostaglandin E 2 (PGE 2 ) production in an autocrine manner. Furthermore, we identify a9b1 integrin as a functional receptor for OPN that mediates its effect and activates ERK and p38 signaling, which ultimately leads to COX-2 expression in macrophages. The major role played by OPN and PGE 2 in angiogenesis are further amplified by upregulation of MMP-9. OPN-activated macrophages promote the migration of endothelial and cancer cells via PGE 2 . These findings provide evidence that TAMs serve as source of key components such as OPN and COX-2-derived PGE 2 and MMP-9 in melanoma microenvironment. Clinical specimens analyses revealed that increased infiltration of OPN-positive TAMs correlate with melanoma growth and angiogenesis. These data provide compelling evidence that OPN and COX-2 expressing macrophages are obligatory factors in melanoma growth. We conclude that OPN signaling is involved in macrophage recruitment into tumor, and our results emphasize the potential role of macrophage in modulation of tumor microenvironment via secretion of OPN, PGE 2 and MMP-9, which trigger angiogenesis and melanoma growth. Thus, blockade of OPN and its regulated signaling network provides unique strategy to eradicate melanoma by manipulating TAMs.
INTRODUCTION
Malignant melanoma is one of the leading causes of death among all the cancer worldwide. During melanoma growth, there is a fine tuned interaction between cancer and stromal cells, which produce a unique microenvironment permissive for tumor growth, metastasis and angiogenesis by secreting a wide array of growth factors, chemokines and proteases. [1] [2] [3] Recent reports suggest that targeting stromal cells can reverse tumor progression. 4, 5 Studying stroma-tumor interaction may solve many unanswered questions, which might aid to design anti-cancer therapy.
Accumulated evidences suggest that inflammatory cells are clearly not innocent bystanders in cancer, but rather have an active role in tumor progression. Among all inflammatory cells in stroma, the most prominent subpopulation is the tumor-associated macrophages (TAMs). Upon activation, macrophages can release various cytokines, proteolytic enzymes, angiogenic factors and inflammatory mediators which profoundly affect many cells in tumor microenvironment that in turn support tumor growth and invasion. [6] [7] [8] Although multiple studies have focused on elucidating the role of infiltrating macrophages in angiogenesis and tumor growth, there has been least characterization of soluble mediators released by macrophages that initiate the phenotypic switch and its potential impact in modulating tumor microenvironment.
Osteopontin (OPN) is secreted non-collagenous, sialic acid rich, chemokine-like phosphoglycoprotein with pleiotropic function. 9 It is widely expressed in various cell types including activated immune cells such as T cells and macrophages. 10 It acts as a ligand for integrins (avb3, avb5, avb1, a9b1 and a4b1) and CD44 variants. 11, 12 OPN is overexpressed in various cancers and growing line of evidence suggests that it has crucial role in all the stages of cancer. [13] [14] [15] [16] The role of tumor-derived OPN in cancer progression and metastasis is extensively studied, whereas the function of stromal OPN in this process is not well defined.
Cyclooxygenase (COX) is a key rate limiting enzyme involved in regulation of prostaglandin synthesis. Among all the isoforms of COX, COX-2 is constitutively expressed in various cancers, predominantly by stromal cells thereby promoting tumor growth and metastasis. 17, 18 Prostaglandin E 2 (PGE 2 ), an important downstream mediator of COX-2, stimulates angiogenesis-specific genes and suppresses the immune system, which cooperatively results in cancer progression. 19, 20 In this study, using both in vitro and in vivo models, we demonstrate the signaling mechanism by which OPN regulates macrophage activation that further controls melanoma growth and angiogenesis. Our findings suggest that OPN via a9 integrin activates p38 and ERK signaling, which ultimately augments COX-2 and MMP-9 expression in macrophages that modulate angiogenesis and melanoma growth.
RESULTS

Lack of expression of OPN reduces microvessel as well as macrophage density thereby attenuates melanoma growth
To elucidate whether OPN signaling on the host side is involved in melanoma growth, we have developed melanoma isograft in Opn þ / þ and Opn knockout (Opn À / À ) mice models. B16F10 cells were injected s.c. into Opn þ / þ and Opn À / À mice. The results indicated that tumor growth was significantly reduced in Opn À / À mice as compared with Opn þ / þ ( Figure 1A , left and right panels). The results provide genetic evidence that lack of host-derived Opn suppresses melanoma growth. To elucidate whether suppression of tumor growth is due to decrease in angiogenesis, we investigated the level of angiogenesis in tumor tissue by immunohistochemical staining with CD31. Figure S3a) . The histopathological analyses of tumor tissues revealed that tumor generated in Opn þ / þ mice exhibit increased immune cell infiltration, higher nuclear polymorphism, mitotic count and enhanced vessel formation as compared with Opn À / À mice (Supplementary Figures S1A, B and Table 1 ). Bianchini et al. 18 have shown that melanoma contained high percentage of COX-2-positive TAMs that can act as an effective biomarker of melanoma growth. Accordingly, tumor sections were analyzed and it was observed that infiltration of COX-2-positive macrophages (F4/80 positive) was remarkably suppressed in tumor tissue of Opn À / À mice as compared with 
Opn
þ / þ (Figures 1B, g and h). As PGE 2 is downstream effector of COX-2, we further examined the serum level of PGE 2 from tumor bearing Opn þ / þ and Opn À / À mice by EIA ( Figure 1E , left panel). Serum level of PGE 2 in Opn þ / þ mice was significantly higher than Opn À / À suggesting the involvement of COX-2 and PGE 2 in melanoma growth and angiogenesis.
To further elucidate the role of COX-2 in melanoma, we studied the effect of COX-2 inhibitor (etoricoxib) on melanoma growth. Significant differences in tumor growth between control (Opn þ / þ ) and etoricoxib-treated group indicated that inhibition of COX-2 significantly suppresses tumor growth ( Figure 1C , left and right panels). The level of angiogenesis was investigated in tumor tissue by immunohistochemistry using anti-CD31 antibody. Microvessel density in tumor tissues were markedly reduced in mice supplemented with etoricoxib ( Figures 1D, a and b) . The infiltration of macrophages into tumor tissues was strikingly suppressed in mice treated with etoricoxib as compared with control ( Figures 1D, c-f) . Also, serum level of PGE 2 was significantly reduced in etoricoxib-treated mice as compared with control ( Figure 1E, right panel) . Moreover, the histopathological analysis showed less immune cell infiltration, vessel formation and mitotic feature in tumor tissue of etoricoxib-treated mice as compared with control (Supplementary Figure S2 and Table 2 ), suggesting that COX-2 has critical role in melanoma growth and angiogenesis. (Figure 2b ). Furthermore, we found that melanoma CM had no effect on COX-2 expression in fibroblasts (Supplementary Figure S3e, lower panel) . These data suggested that melanoma-derived factor(s) upon interaction with macrophages augments COX-2 expression and PGE 2 production.
Our in vivo experimental data indicated that there was increase in migration of macrophages in melanoma, whereas COX-2 inhibitor reduced the infiltration of macrophages. Further to understand the mechanism involved in macrophage infiltration in melanoma, we have used in vitro model system involving co-migration of macrophages (RAW264.7) with CM of melanoma. The results revealed that CM of melanoma induces macrophage migration and macrophages transfected with OPN or COX-2 cDNA showed enhanced migration, whereas cells transfected with small interfering RNA (siRNA) specific to OPN or COX-2 significantly lost their ability to migrate (Figure 2c We next sought to determine whether exogenous OPN would be sufficient to increase COX-2 expression in macrophages instead of melanoma CM. Accordingly, RAW264.7, pMac or IC21 cells were subjected to exogenous OPN in a dose (0-1 mM) and time The specificity of OPN on COX-2 expression was further established by transfecting the RAW264.7 with OPN cDNA or siRNA or treating with exogenous human and mouse OPN. The data showed that OPN cDNA enhanced whereas OPN siRNA suppressed COX-2 expression in these cells ( Figure 3d , left panel). The level of PGE 2 from the CM of OPN-treated RAW264.7 was detected by EIA and significant induction of PGE 2 production by OPN was observed in these cells ( Figure 3d , right panel). We have further demonstrated that OPN specifically induced COX-2 expression in macrophages but has no effect in melanoma or fibroblast cells (Supplementary Figure Increased expression of ICAM either in tumor or endothelial cells correlates with tumor progression and angiogenesis. 16, 29 To investigate whether OPN-activated macrophages induce ICAM expression and role of ICAM on endothelial cell migration and angiogenesis, we have performed co-culture and tube formation experiments using RAW264.7 and human umbilical vein endothelial cell (HUVEC) cells. The results revealed that (Figures 5a-c) . The data suggested that OPN triggers the pro-angiogenic activity in macrophages. VEGF is potent angiogenic molecule reportedly involved in various cancer progressions. Previously, we have reported that OPN-induced VEGF expression and VEGF-dependent angiogenesis in breast cancer model. 15 Surprisingly, coculture with RAW264.7 and B16F10 cells or vice-versa have no Figure S5c) . We also examined whether OPN has any role in M2-specific receptor, CD206 expression. Accordingly, RAW264.7 cells were treated with OPN and the results indicate that OPN does not induce CD206 expression in these cells (Figure 6a ). OPN induces ERK1/2 and p38-mediated AP-1-dependent COX-2 and MMP-9 expression To further elucidate the signaling mechanism involved in OPNinduced COX-2 expression in macrophages, we checked the effect of OPN on phosphorylation of ERK and p38 in RAW264.7 cells. The results indicated that OPN induces phosphorylation of ERK and p38 in these cells (Figure 6b and Supplementary Figure S5d) . To decipher the signaling mechanism involved in OPN-induced COX-2 expression, cells were treated with inhibitors of ERK (PD98059), p38 (SB203580), JNK (SP600125) and Akt (LY294002 and Wortmannin) and the results revealed that OPN induces COX-2 expression through ERK and p38 but not by JNK-and Aktdependent pathway (Supplementary Figure S5e) . Furthermore, OPN-induced COX-2 expression was drastically inhibited by combination of ERK and p38 inhibitor (Figure 6c, upper panel) . The data indicate that both ERK and p38 are involved in OPNinduced COX-2 expression. Moreover, inhibitors of ERK, p38 and COX-2 dramatically suppressed OPN-induced PGE 2 production in RAW264.7 cells (Figure 6c, lower panel) .
To delineate the role of AP-1 and its component in OPNinduced COX-2 expression in macrophages, RAW264. MMPs expression has been implicated in tumor progression through enhancing angiogenesis, tumor invasion and metastasis. [30] [31] [32] To further study the effect of OPN in MMP-9 expression, RAW264.7 cells were either treated with OPN or pretreated with inhibitors of ERK, p38 or COX-2 and then treated with OPN. The expression of MMP-9 was analyzed by western blot and zymography. The data indicate that ERK, p38 and COX-2 have significant role in OPN-induced MMP-9 expression in these cells (Figure 6g , left and right panels). Moreover, PGE 2 enhances MMP-9 expression (Supplementary Figure S5f) . OPN-activated macrophages enhance melanoma cell migration through paracrine mechanism To explore whether OPN-activated macrophages regulate melanoma cell migration, co-migration experiments were performed. The results suggest that COX-2 inhibitors or COX-2 siRNA blocks OPN-activated macrophages induced melanoma cell migration ( Figure 7A; Supplementary Figure S6A , left and right panels). PGE 2 also induces melanoma cell migration (Supplementary Figure S6B, left and right panels). These data suggested that OPN-activated macrophages induce melanoma cell motility via COX-2/PGE 2 .
Infiltrating macrophages in melanoma specimens are OPN and COX-2 positive that correlates with angiogenesis and melanoma growth We have further extended the in vitro and animal data in human clinical specimens. Human melanoma tissues were sectioned, stained with H&E and graded as malignant with the help of expert histopathologist. Melanoma specimens were stained with antibodies against OPN, COX-2, CD31 and CD68 (marker of TAMs). The data revealed that there was increased infiltration of macrophages in malignant melanoma as compared with peripheral normal specimens ( Figures 7B, c and d) . Immunofluorescence double staining confirmed the colocalization of OPN and COX-2 with CD68 and demonstrated that majority of TAMs express OPN and COX-2 ( Figures 7B and C, e and f) . Expression of CD31 was also analyzed by immunohistochemistry and the results showed increased infiltration of OPN-and COX-2-positive macrophage correlates with enhanced angiogenesis in malignant tumor ( Figures 7B, g and h) . Moreover, OPN was overexpressed in infiltrating macrophages (macrophages within tumor mass) of malignant melanoma. Very few OPN þ TAMs were observed along the tumor margin in surrounding area (Supplementary Figure S6c) .
DISCUSSION
In the present study, we sought to investigate signaling events driven by OPN-activated macrophages that initiate the phenotypic switch in macrophages and its potential impact on the remodeling of melanoma microenvironment. Our study delineates the novel mechanism where tumor-educated macrophages overexpress OPN that not only favor macrophages infiltration but also drives these cells toward an angiogenic phenotype that facilitates melanoma growth. Further, we demonstrate that OPN via a9 integrin activates p38 and ERK signaling pathways which ultimately leads to COX-2 expression and PGE 2 production. The OPN-activated macrophage promotes angiogenesis via PGE 2 and augments MMP-9 expression. The clinical data suggested the increased infiltration of OPN and COX-2-positive TAMs correlate with enhanced tumor growth and angiogenesis. In summary, our results highlight the crucial role of OPN-activated macrophage in melanoma growth and further suggested that OPN-regulated signaling in TAMs may provide novel therapeutic strategy for the treatment of malignant melanoma. The increased infiltration of TAMs in melanoma correlates with enhanced angiogenesis, which ultimately modulates tumor growth. Here, we have observed that melanoma growth was drastically suppressed in Opn À / À mice as compared with Opn þ / þ . In this study, we found that increased infiltration of OPN and COX-2-positive macrophages correlate with increased angiogenesis and melanoma growth. Bachmann et al. 33 have shown that in melanoma, tumor necrosis is closely associated with increased tumor thickness and angiogenesis. Leek et al. 21 have demonstrated that increased infiltration of TAMs in necrotic area of breast cancer correlate with angiogenesis and poor prognosis. Here, we observed enhanced tumor necrosis in melanoma tissue of Opn þ / þ mice. Moreover, our data also revealed that increased infiltration of TAMs in melanoma correlate with necrosis and other aggressive phenotype of tumor. Moreover, in clinical specimens, we observed that infiltrating macrophages in necrotic area (hotspot TAMs) exhibits high level of OPN expression which correlates with enhanced angiogenesis. Taken together, the results suggest that rapidly growing melanoma generates necrosis which in turn recruits macrophages and these tumor-educated macrophages contributes to angiogenesis.
Role of tumor-derived OPN in various cancer progressions is well documented but the function of macrophage-derived OPN is paradoxical as it participates in both tumorigenesis and tumoricidal activities. [34] [35] [36] Recent reports indicate that Opn is one of the highly upregulated gene in TAMs in various cancer. [37] [38] [39] [40] Recently, it has been reported that OPN is overexpressed in macrophages upon co-culture with breast cancer cells. 41 Furthermore, Cheng et al. 42 have reported that macrophagederived OPN restore the metastatic potential of OPN-knockdown tumor cells. Here, we observed that OPN is overexpressed in macrophages upon co-culture with melanoma cells. Moreover, we found that expression of OPN and COX-2 in macrophages was significantly higher as compared with tumor cells indicating that TAMs may serve as major source of OPN and COX-2 in tumor microenvironment. In this study, we found that OPN induces COX-2 expression via a9b1 integrin in RGD-independent manner.
Tumor-educated macrophages regulate angiogenesis in tumor microenvironment by secreting a wide range of factors. 43 Our results indicated that OPN-activated RAW264.7 cells augment the secretion of PGE 2 which in turn induce endothelial cell migration and tube formation. Furthermore, CAM assay validate this finding. In this study, the increased expression of COX-2, MMP-9 and elevated level of PGE 2 revealed that OPN-activated macrophages trigger the angiogenic phenotype of macrophages. Recently, Nakanishi et al. 44 have shown that COX-2 inhibition altered TAMs phenotypes by redirecting TAMs toward M1 phenotype. Moreover, Heusinkveld et al. 45 have demonstrated that tumor-derived PGE 2 is responsible for differentiation of monocytes to M2 macrophages. Enhanced COX-2 expression and PGE 2 production in OPN-activated macrophages further support the notion that increased expression of OPN in tumor-educated macrophages redirects the TAMs towards M2 phenotype. Phenotypic hallmark of M2 macrophages is due to increased expression of mannose receptor (CD206). We have checked the effect of OPN on CD206 and the result indicates that OPN has no effect on CD206 expression.
In this study, we have shown that soluble mediator derived from melanoma cells induces OPN and COX-2 expression thereby promoting macrophages migration. The further characterization of soluble factor(s) secreted by tumor cells that induced OPN expression in macrophage is in progress. Green et al. 46 have shown that RAW264.7 macrophages promote the migration and invasion of colon carcinoma cells. Here, we found that OPN activates ERK and p38 pathway, which leads to COX-2-dependent PGE 2 production and melanoma cell migration. TAMs express a wide array of angiogenesis modulating enzymes including MMP-9.
30,31 TAMs-derived MMP-9 has been shown to be crucial for angiogenesis in cervical carcinogenesis. 32 Here, we found that OPN induces COX-2-dependent MMP-9 expression in macrophages suggesting that OPN-activated macrophage has crucial role in tumor angiogenesis.
In conclusion, we herein provide direct evidence that tumoreducated macrophages modulate melanoma microenvironment via secretion of OPN, PGE 2 and MMP-9, which effectively regulates melanoma growth and angiogenesis. Our data indicate that macrophage-derived OPN educates macrophages towards cancer promoting phenotype through upregulation of COX-2. These data suggested that disrupting the communication between TAMs and cancer cells may redirect the macrophages function and blockade of OPN-regulated signaling may provide means of targeting tumor growth and angiogenesis ( Figure 7D ).
MATERIALS AND METHODS
Cell lines and transfections
The mouse macrophage (RAW264.7, IC21) and melanoma (B16F10), human melanoma (A375) cells were obtained from American Type Culture Collection (Manassas, VA, USA). HUVEC were purchased from Lonza (Walkersville MD, USA). OPN cDNA (Dr Georg F. Weber, University of Cincinnati, OH, USA) and COX-2 cDNA (Dr Stephen Prescott, University of Utah, UT, USA) were transfected in RAW264.7 cells using lipofectamine 2000 and used for further experiments.
Isolation of peritoneal macrophages (pMac)
The pMac were isolated by flushing the peritoneal cavity of C57BL/6J mice with RPMI medium. Peritoneal exudate cells were collected and allowed to adhere in 6-well plate at 37 1C. After 2 h, nonadherent cells were removed. The preparation contains 95% macrophages as verified by flow cytometry using PE-CD11b (BD Pharmingen, San Diego, CA, USA) staining.
Isolation of mouse embryonic fibroblasts (MEFs) E13.5 embryos from C57BL/6J mice were obtained and MEFs were isolated as described. 47 In vivo tumorigenicity and immunohistochemistry All animal experiments were carried out according to institutional guidelines, following a protocol approved by the animal ethics committees of National Center for Cell Science. Opn À / À mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA). Briefly, B16F10 cells (1 Â 10 6 )
were injected s.c. into the dorsal side of Opn þ / þ and Opn À / À mice (6-8 weeks old). In separate experiments, B16F10 cells (1 Â 10 6 ) were injected s.c. into the dorsal side of control (C57BL/6J) mice. After 1 week, Etoricoxib (10 mg/kg body weight) was injected i.p. into the mice. After 4 weeks, mice were killed and tumors were excised, weighed and volumes were plotted against time. Tumor volumes were estimated using the formula: p/6 [(d1 Â d2) 3/2 ]. Tumor sections were analyzed by immunohistochemistry using anti-F4/80, anti-CD31, anti-CD11b and anti-COX-2 antibodies followed by incubation with appropriate secondary antibodies and analyzed by BD pathway 855.
Purification of human OPN
The human OPN was purified from breast milk with minor modification and used throughout the study. 48 
Estimation of PGE 2
The level of PGE 2 from the CM of RAW264.7 cells or pMac and mice sera was determined using PGE 2 EIA kit (Assay Design, Farmingdale, NY, USA).
Small interfering RNA RAW264.7 cells were transfected with siRNA that specifically targeting OPN (siGENOMESMARTpool mouse SPP1, Dharmacon International, Lafayette, CO, USA), CD44 (CD44 siRNA), integrin a9 (integrin a9 siRNA) and COX-2 (COX-2 siRNA) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) with lipofectamine 2000.
Western blot
The western blot was performed as described earlier. 49 Briefly, the expression of OPN and VEGF (Sigma, St Louis, MO, USA), COX-2, integrin a9, CD44, p38, ERK1/2, c-Fos, c-Jun, actin (Santa Cruz Biotechnology) and p-p38, p-ERK1/2 (Cell Signaling Technology, Beverly, MA, USA) and MMP-9 (Chemicon, Temecula, CA, USA) of treated or transfected RAW264.7 or pMac or HUVEC or B16F10 cells were analyzed by western blot.
Immunofluorescence
The immunofluorescence was carried out as described. 50 
Zymography
The zymography was performed as described. 51 Briefly, RAW264.7 cells were either treated with OPN or pretreated with SB203580, PD98059 or NS-398 (Calbiochem, La Jolla, CA, USA) and then treated with OPN. Gelatinolytic activity of MMP-9 from CM was detected by zymography.
Cell migration and co-migration assay
The migration and co-migration assay was performed using Transwell cell culture chambers (Corning, Corning, NY, USA) as described. 52 The migrated cells were stained with Giemsa and counted in four high-power fields (C/HPF) under an inverted microscope (Nikon, Melville, NY, USA) and analyzed.
CAM assay
On day 4, the CAM of fertilized white leghorn chicken eggs was added with uniform-sized sterilized gelatin sponges loaded with CM of RAW264.7 cells either treated with 0.5 mM OPN or pretreated with NS-398 or Etoricoxib and then treated with OPN. CAM was photographed in ovo with a stereomicroscope equipped with a camera. At day 6, the angiogenic response was evaluated as length and size of vessels. The in ovo angiogenesis was quantified using the Angioquant software.
Tube formation assay HUVEC (1 Â 10 4 cells) were seeded into a matrigel-coated 96-well plate. Then, CM of RAW264.7 cells either treated with OPN or pretreated with NS-398 or Etoricoxib and then treated with OPN were added to the HUVEC. After 4 h, photographs were taken under microscope (Nikon).
Wound assay
Wound assays were performed using endothelial cells as described earlier. 52 OPN-activated macrophages induce melanoma growth and angiogenesis S Kale et al
Human melanoma specimens analyses
Human melanoma specimens were collected with the help of histopathologist from the local hospital with informed consent. The specimens were analyzed by immunohistochemistry using anti-CD31, anti-OPN, anti-COX-2 and anti-CD68 antibodies followed by incubation with secondary antibodies and analyzed by BD pathway 855.
Statistical analysis
Statistical differences were determined by Student's 't' test using Sigma plot software. A P-value of o0.05 was considered significant. All bands were analyzed densitometrically (Kodak Digital Science, Rochester, NY, USA) and fold changes were calculated. Wound assay and in vitro tube formation data were quantified using Image Pro plus 6.0 software (Media Cybernetics, Rockville, MD, USA).
